Category : Search result: clinical trial


Tropical Plant Serum Doubles Hair Thickness in Trial

A new scalp serum combining Centella asiatica plant cells with lab-engineered growth factors more than doubled hair thickness and density in a clinical study. Discover the promising science behind this hair loss breakthrough.

Cancer Vaccine Could Be Ready in a Decade, Say UK Scientists

Oxford researchers are developing a groundbreaking multi-cancer vaccine, with human trials for a lung cancer jab starting in 2026. This NHS-administered shot could prevent millions of deaths globally. Discover the story behind this medical revolution.

US Awards $1.6m No-Bid Contract for Hep B Study

The Trump administration awards a controversial $1.6 million contract to Danish scientists for a hepatitis B vaccine study on African newborns, raising major ethical concerns. Read the full investigation.

CDC Panel Limits Hepatitis B Vaccine for Newborns

CDC vaccine advisers have voted to restrict the hepatitis B vaccine for newborns, a major change to a decades-old policy. Learn what this means for infant health and vaccine access.

Postcode lottery for child brain cancer care in UK

A damning report reveals a child's NHS brain tumour care depends on where they live, with uneven access to tests, rehab, and trials. Calls for urgent action to end the postcode lottery.

Metformin reduces insulin need in type 1 diabetes

Australian clinical trial reveals metformin, an affordable century-old medication, reduces insulin requirements by 12% for type 1 diabetes patients. Discover how this breakthrough could transform diabetes management in the UK.

Novo Nordisk Alzheimer's drug trial fails

A major study testing Novo Nordisk's semaglutide for Alzheimer's disease has failed, dealing a blow to hopes of a new treatment for over 55 million patients. Discover the full story.

New TB drug shows breakthrough potential in trial

Sorfequiline, a new antibiotic, demonstrates stronger action against tuberculosis with potential to revolutionise treatment. Could this be the breakthrough against the killer disease?

NIH cuts disrupt 74,000 in medical trials

A new report reveals how NIH funding cuts have disrupted over 74,000 people in clinical trials, impacting research for cancer, heart disease, and COVID-19. Discover the full consequences.

Page 1 of 4